Tobacco Use, Perceptions, and Characteristics of Adults Who Use IQOS® in the United States: Findings from a Cross-Sectional Study

Author:

Cheng Hui G.1,Noggle Brendan1,Vansickel Andrea R.1,Largo Edward G.1,Magnani Pierpaolo2,Heremans Annie2

Affiliation:

1. Altria Client Services LLC Center for Research and Technology

2. PMI R&D, Philip Morris Products S.A

Abstract

Abstract Background The smoke-free heated tobacco product IQOS® was introduced in the United States (US) in 2019 and authorized by the US Food and Drug Administration as a modified risk tobacco product (MRTP) in 2020. The aim of this study was to describe selected sociodemographic characteristics of adults who used IQOS® (AUI), tobacco use patterns relevant to IQOS® use (e.g., tobacco use history, exclusive and dual-use, switching from cigarette smoking, etc.), risk perceptions of IQOS®, and understanding of IQOS® MRTP messages among AUI.Methods The IQOS® cross-sectional Postmarket Adult Consumer Study was a study of AUI aged ≥ 21 years who were recruited from an IQOS® consumer database via direct mail and emails. Participants completed the online survey between September and November 2021.Results The survey was completed by 645 current and 43 former AUI who had used at least 100 Marlboro® HeatSticks® prior to the assessment. Of the 688 participants, 61% were male, 73% were non-Hispanic white, and the mean age was 45. The vast majority (99%) of AUI had ever smoked combusted cigarettes before first trying IQOS®. At the time of assessment, 49% were still smoking after an average of 1 year of IQOS® use. Among those, 83.6% smoked fewer cigarettes compared to before first trying IQOS®. Among all AUI, over 80% had never used a cessation treatment or had not used it in the past 12 months. Approximately 80% of AUI demonstrated correct understanding of the MRTP message.Conclusions This study is the first to provide evidence that IQOS® can help adult smokers in the US completely switch away from cigarettes or reduce smoking.

Publisher

Research Square Platform LLC

Reference37 articles.

1. Risk Factors Collaborators. Global burden of 87 risk factors in 204 countries and territories, 1990–2019: a systematic analysis for the Global Burden of Disease Study 2019;Lancet,2020

2. US Department of Health and Human Services: Smoking Cessation: A Report of the Surgeon General- Executive Summary. 2020.

3. Quitting Smoking Among Adults - United States, 2000–2015;Babb S;MMWR Morb Mortal Wkly Rep,2017

4. Probability and predictors of relapse to smoking: results of the National Epidemiologic Survey on Alcohol and Related Conditions (NESARC);Garcia-Rodriguez O;Drug Alcohol Depend,2013

5. Fiore MC, Jaén CR, Baker TB, Bailey WC, Benowitz NL, Curry SJ, et al. Treating tobacco use and dependence: 2008 update. Rockville, MD: Public Health Service. 2008.

Cited by 1 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3